Related Experiment Video
Updated: Mar 16, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Chronological Diagnostic Algorithm Predicting Neuropathology in Parkinsonism
Daisuke Ono1,2,3, Hiroaki Sekiya1, Alexia R Maier1
1Department of Neuroscience, Mayo Clinic, Jacksonville, FL.
A new machine learning algorithm accurately predicts parkinsonism neuropathology using clinical history. This tool aids in early diagnosis and treatment, improving patient outcomes for complex neurological conditions.
Area of Science:
- Neurology
- Artificial Intelligence
- Medical Diagnostics
Background:
- Pre-mortem diagnosis of parkinsonism is challenging due to diverse presentations and overlapping conditions.
- Accurate neuropathological diagnosis is crucial for effective treatment and research.
Purpose of the Study:
- To develop and validate a machine learning algorithm for predicting parkinsonism neuropathology.
- To utilize chronological clinical data for improved diagnostic accuracy.
Main Methods:
- Automated abstraction of clinical data from medical records using Generative Pre-trained Transformer 4 (GPT-4) models.
- Training six machine learning models on patient data, including age, sex, family history, and 197 clinical presentations.
- Predicting nine neuropathologic diagnoses, including Lewy body disease (LBD), Alzheimer's disease (AD), progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and frontotemporal lobar degeneration (FTLD).
Main Results:
- The CatBoost algorithm achieved an area under the receiver operating characteristic curve (AUC) of 0.83 for predicting neuropathology three years post-onset.
- Key predictors included age at onset, restricted eye movement, and tremor.
- The model demonstrated robustness with incomplete data, achieving an AUC of 0.80 using only 23 of 200 parameters.
Conclusions:
- The developed algorithm serves as a cost-effective and interpretable screening tool for parkinsonism.
- This tool can aid in bridging biomarker testing and the development of molecular-targeted therapies.
- The algorithm provides diagnostic probabilities and visualizations, facilitating clinical decision-making.
More Related Videos
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Related Concept Videos
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neural Regulation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...